Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress

Parallel Session 2403

Restless Legs Syndrome

Monday, October 5, 2026
14:00 - 15:30 | Conference Room North 202, Level 2

In this session, the faculty will review the pathophysiology of Restless Legs System (RLS) including briefly reviewing the common secondary causes. In addition, the typical and atypical clinical presentations including common triggers will be discussed. Lastly, the new treatment guidelines and the use of devices and other non-pharmacological treatments will be reviewed.

Chairs:

Han-Joon Kim, Korea
Federica Provini, Italy

Presenters:

Pathophysiology of RLS

Diagnosis of Typical and Atypical RLS

Treatment Updates

CSPC Liaison(s):

Harini Sarva, USA

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Identify the complex pathophysiology of primary and secondary RLS including contributions of genetics role of neurochemicals, iron, and systemic illnesses
  2. Recognize the typical and atypical clinical presentations of RLS
  3. Appreciate the new treatment guidelines for RLS and the role of devices and complimentary therapies

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)

Education Level

Beginner / Foundational
Intermediate / Experienced